About Tiba Aynechi
Tiba Aynechi is a director at MBX Biosciences.
Form D filings name Tiba Aynechi as a director at Rezo Therapeutics and Avalyn Pharma.
Tiba Aynechi reports to the SEC as a director of 5 public companies, including Spruce Biosciences (SPRB), Nkarta (NKTX) and Mirum Pharmaceuticals (MIRM).
Tiba Aynechi first appears on SEC filings in 2016.
Experience
This experience comes from SEC filings. The years are when the filings name Tiba Aynechi in the role, so the role may have started earlier or lasted longer.
MI
MBX Biosciences, Inc.
Director
2024 – 2026 · Public company (MBX)
SI
Spruce Biosciences, Inc.
Director
2020 – 2025 · Public company (SPRB)
NI
Nkarta, Inc.
Director
2020 – 2022 · Public company (NKTX)
MI
Mirum Pharmaceuticals, Inc.
Director
2019 · Public company (MIRM)
II
iRhythm Holdings, Inc.
Director
2016 – 2017 · Public company (IRTC)
Key Colleagues at Startups
The people Tiba Aynechi works with at each company, as listed on that company's latest Form D.
Rezo Therapeutics, Inc. · Form D/A, Aug 18, 2025
SG
Simeon George
Director
DH
Derek Hicks
Executive officer and director
NK
Nevan Krogan
Executive officer and director
JC
Jennifer Chang
Secretary
GS
George Scangos
Director
NB
Norbert Bischofberger
Director
Vineeta Agarwala
Director
Avalyn Pharma Inc. · Form D, Oct 10, 2023
LB
Lyn Baranowski
Chief Executive Officer and director
KP
Ketan Patel
Director
PM
Peter Moldt
Director
ND
Niall O'Donnell
Director
CL
Cassandra Luca
Director
JL
Jonathan Leff
Director
JC
Jill Carroll
Director